Patient demographics and outcome summary
| Demographic | n (n=78) |
| Gender, male (%) | 58 (64.1) |
| Age, years, median (IQR) | 59 (53.9–67) |
| Obesity (%) | 23 (29.5) |
| Smoking (%) | 7 (9.0) |
| Black and minority ethnic (%) | 3 (3.8) |
| Acute Physiology and Chronic Health Evaluation II Score, median (IQR) | 16 (11–19.3) |
| Critical care length of stay, days, median (IQR) | 9.1 (4.9–25.1) |
| Hospital length of stay, days, median (IQR) | 20 (12–45.3) |
| Ventilated (%) | 47 (60.3) |
| Renal replacement therapy required (%) | 14 (17.9) |
| Comorbidities (%) | |
| Respiratory | 25 (32.1) |
| Endocrine | 19 (24.4) |
| Hypertension | 29 (37.2) |
| Cardiovascular | 10 (12.8) |
| Liver | 1 (1.3) |
| Gastrointestinal | 9 (11.5) |
| Mental health | 10 (12.8) |
| Other | 18 (23.1) |
| Multimorbidity (two or more comorbidities) | 39 (50) |
| Scottish Index of Multiple Deprivation (SIMD) quintile (%)* | |
| SIMD 1 (most deprived) | 27 (34.6) |
| SIMD 2 | 13 (16.7) |
| SIMD 3 | 17 (21.8) |
| SIMD 4 | 8 (10.2) |
| SIMD 5 (least deprived) | 12 (15.4) |
| SIMD missing | 1 (1.3) |
| Medication management | |
| Median number of medications pre critical care (IQR) | 5 (1–8) |
| Median number of medications at hospital discharge (IQR) | 5 (2–7) |
| Median number of medications at clinic attendance (IQR) | 5 (3–8) |
| Patients requiring new or increased medications (measured at clinic) following COVID-19 (%) | 56 (71.8) |
| Pain medication management (%) | |
| Number of patients on pain medication pre critical care (steps 1–3 on WHO pain ladder) | 23 (29.5) |
| Number of patients on pain medication at clinic attendance (steps 1–3 on WHO pain ladder) | 39 (50) |
*The SIMD, produced by the Scottish Government as a measure of deprivation, defined socioeconomic status.